COMMUNIQUÉS West-GlobeNewswire

Natus Medical Announces 2018 Annual and First Quarter Financial Guidance

08/01/2018 - 12:50

Announces Fourth Quarter preliminary revenue results Announces Fourth Quarter 2017 Financial Results Conference Call Date PLEASANTON, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) [...]

K2M Group Holdings, Inc. Reports Preliminary Fourth Quarter and Full Year 2017 Financial Results

08/01/2018 - 12:45

LEESBURG, Va., Jan. 08, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]

ChromaDex and Watsons Expand Partnership with TRU NIAGEN™ Retail Launch in Singapore

08/01/2018 - 12:30

IRVINE, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), a fully integrated, science-based, nutraceutical company devoted to improving the way people age, announced the launch of TRU NIAGEN ™ [...]

Avivagen Announces Positive Results from Dairy Cattle Trial

08/01/2018 - 12:30

OTTAWA, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product intended to replace the use [...]

Integra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Results

08/01/2018 - 12:30

Preliminary Fourth Quarter Highlights: Fourth quarter 2017 reported revenue is expected to be approximately $365 million, exceeding the high-end of the company’s previous implied guidance range of $345 million to $355 [...]

Emergent BioSolutions Announces Preliminary 2017 Financial Results and Provides 2018 Financial Outlook

08/01/2018 - 12:30

GAITHERSBURG, Md., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) today announced preliminary unaudited 2017 financial results and guidance for 2018. Daniel J. Abdun-Nabi, president and chief [...]

US ARMY Fully Funds Spider Silk Development Contract with Kraig Biocraft Laboratories

08/01/2018 - 12:05

ANN ARBOR, Mich., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the US ARMY has fully funded its [...]

BeiGene and Mirati Therapeutics Announce Exclusive License Agreement for Sitravatinib in the Asia Pacific Region

08/01/2018 - 12:00

CAMBRIDGE, Mass. and BEIJING, China and SAN DIEGO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Acura Pharmaceuticals Announces Successful Results from Study AP-LTX-301

08/01/2018 - 12:00

PALATINE, Ill., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs , today announced that topline results from clinical study [...]

Enable Injections Achieves ISO 13485:2016 Certification to Meet Mounting Demand for Drug-Delivery Device Combination Products

08/01/2018 - 12:00

CINCINNATI, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Enable Injections , Inc., developer of the advanced enFuse™ large volume wearable injectors (LVWI) platform for subcutaneous delivery of biologics, has been awarded the [...]

Dynavax Announces HEPLISAV-B™ is Now Available in the United States for the Prevention of Hepatitis B in Adults

08/01/2018 - 12:00

BERKELEY, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today announced that HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant), Adjuvanted] is now available in the United States [...]

Tecan to present at J.P. Morgan Healthcare Conference

08/01/2018 - 11:01

Männedorf, Switzerland, January 8, 2018 - The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will present at J.P. Morgan Healthcare Conference on January 11, 2018. The investor presentation by David [...]

Wright Medical Group N.V. Announces Preliminary Fourth Quarter and Full-Year 2017 Net Sales

08/01/2018 - 11:00

Fourth Quarter 2017 Net Sales of Approximately $218 Million Full-Year 2017 Net Sales of Approximately $745 Million At High-End Of Company’s Previously Provided 2017 Guidance Range Company to Present Today at J.P. Morgan [...]

APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi

08/01/2018 - 09:02

VIENNA, Austria and HAMBURG, Germany, Jan. 08, 2018 (GLOBE NEWSWIRE) -- APEIRON Biologics AG, a company focused on cancer immunotherapy, and Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) [...]

Saniona AB: Saniona reports top line results from the Tesomet Phase 2a interim study in Prader-Willi syndrome

08/01/2018 - 08:01

PRESS RELEASE January 8, 2018 Saniona, a leading biotech company in the field of ion channels, today announced top line results from its exploratory Phase 2a clinical trial for Tesomet in patients with Prader-Willi [...]

WORLD RENOWNED IMMUNOLOGIST, PROFESSOR ERIC VIVIER, JOINS INNATE PHARMA AS CHIEF SCIENTIFIC OFFICER

08/01/2018 - 07:01

WORLD RENOWNED IMMUNOLOGIST, PROFESSOR ERIC VIVIER, JOINS INNATE PHARMA AS CHIEF SCIENTIFIC OFFICER Marseille, France, January 8, 2018 Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today [...]

IMMUNOLOGISTE DE RENOMMÉE MONDIALE, LE PROFESSEUR ÉRIC VIVIER EST NOMMÉ DIRECTEUR SCIENTIFIQUE D'INNATE PHARMA

08/01/2018 - 07:01

IMMUNOLOGISTE DE RENOMMÉE MONDIALE, LE PROFESSEUR ÉRIC VIVIER EST NOMMÉ DIRECTEUR SCIENTIFIQUE D'INNATE PHARMA Marseille, le 8 janvier 2018 Innate Pharma SA (la « Société » - Euronext Paris : FR0010331421 - IPH) annonce [...]

Addex Therapeutics Equity Research Report Update Issued by valuationLAB

08/01/2018 - 07:01

Report estimates a current value of ADXN of CHF 12.5 per share Geneva, Switzerland, 8 January 2018 - Addex Therapeutics (SIX: ADXN) announced today that the independent life science equity research firm, valuationLAB AG [...]

Targovax announces the appointment of Michael Bogenstaetter as Chief Business Officer

08/01/2018 - 07:01

Oslo, Norway, 8 January 2018: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that Michael Bogenstaetter [...]